Year in industry placement

Location of role
Oxford, UK

Department
Commercial

Key Responsibilities
Purpose of the role

To provide the foundational evidence for Market Access and reimbursement of KIMMTRAK (tebentafusp) for the second proposed indication, treatment of HLA-A*02:01 adult patients with advanced (stage IV) cutaneous melanoma whose disease has progressed following prior treatments.

The evidence will include:

• review of published scientific evidence
• data and statistical analyses and modelling of data; and,
• preparation of advice with government agencies across multiple countries in Europe, such as for Health Technology Assessment by the National Institute for Health and Care Excellence (NICE) in the UK.
• Additional objectives will include updates to evidence, and negotiations for contracts and price renewals for the approved indication in advanced uveal melanoma across multiple countries.

Key Responsibilities

The selected candidate will have the opportunity to develop their skills in translating research into compelling written reviews and conclusions, whilst learning how the outputs from R&D can be progressed to a medicine being made routinely available to all eligible patients on the public healthcare system, such as on the NHS in the UK. The project will also provide the student with an excellent opportunity to learn how a medicine is developed and commercialised across multiple countries.

Additional key skills the student will develop include: (i) demonstrating leadership via expertise; (ii) project management; and, (iii) presentation and communication skills, which will build on the student's scientific knowledge / skills gained during their university studies. The student will have the opportunity to learn from other departments in R&D and the broader Commercial and Medical teams outside of the Market Access team to gain an understanding of how a pharmaceutical company provides new medicines to patients.

Education & Qualifications

• Currently studying towards a biological sciences degree, such as pharmacology, biochemistry or biotechnology.
• An individual who has a willingness to work independently with guidance from the team, challenge assumptions, listen to in-country experts and provide evidence-based insights across multiple countries.
• Proven experience working within teams and taking responsibility for their progress toward fulfilling the team's objectives.

What will you receive?

Join Immunocore for a paid placement and gain insights from our innovative science and corporate growth. You'll enjoy 25 days of annual leave (pro rata), pension scheme eligibility, and access to our active Sports and Social Club with subsidized events.

Please note this is a full-time position is based at our Abingdon, Oxfordshire office and contracted through a third party.

Important information for all applicants

The application deadline is 09th January 2026, with phone interviews starting shortly after. Shortlisted candidates will be invited to an in-person Assessment Centre on 23rd, 24th ,25th , or 26th February 2026, providing an opportunity to meet current placement students, learn about the role, and socialize with employees.

Placements are expected to begin on 7th September 2026.

Please note - should you not be available on all the above dates, unfortunately, we won't be able to proceed with your application.

Please only apply if you are currently undergoing a degree with a placement year (sandwich year).

If interested, apply with your CV and a cover letter (combined in one document) stating your main areas of interest.

About the Company
Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some of the biotech industry's most successful drug developers. We are creating not just an environment where great minds can interact but an innovation powerhouse answering the big questions.

Focused on delivering first-in-class biological therapies to patients, we have developed a highly innovative soluble TCR platform. Our ImmTAX molecules underpin a new generation of precision engineered drugs that harness the immune system to treat a broad spectrum of diseases with high unmet medical need, including oncology, infectious diseases and autoimmune diseases.

At Immunocore, we recognize that our employees are our greatest asset. We value the unique contributions each person brings to our team. By embracing Science, Trust, Respect, Integrity, Diversity, and Entrepreneurship (STRIDE), we create an environment where collaboration thrives, ideas flourish, and transformative changes happen. STRIDE represents more than just letters; it embodies our shared identity and drives our mission. We are dedicated to developing breakthrough therapies that transform patients' lives, advancing medicine, and supporting one another in these pursuits.

Immunocore is proud to be an equal opportunity employer. As such, we are committed to fostering an inclusive workplace where everyone feels valued, respected, and empowered. We encourage applications from individuals of all backgrounds, regardless of race, color, religion, sex, sexual orientation, gender identity or expression, pregnancy, age, national origin, disability status, or any other characteristic protected by law.